What do we know about phytotherapy of benign prostatic hyperplasia?

Area of Science:

• Urology
• Pharmacognosy
• Integrative Medicine

Background:

• Benign prostatic hyperplasia (BPH) is a prevalent urological condition in aging men.
• Its long latency period makes BPH a suitable target for preventive strategies.
• Phytotherapy presents an alternative or complementary approach to conventional treatments.

Purpose of the Study:

• To review current phytotherapeutic treatment options for benign prostatic hyperplasia (BPH).
• To evaluate the efficacy and safety of various herbal medicines used for BPH.
• To inform healthcare professionals about the role of phytotherapy in BPH management.

Main Methods:

• Systematic review of available literature on phytotherapy for BPH.
• Analysis of preclinical studies investigating mechanisms of action.
• Evaluation of randomized clinical trials assessing efficacy and adverse effects.

Main Results:

• Herbal medicines like Serenoa repens, Pygeum africanum, and Urtica dioica are used for mild-moderate BPH symptoms.
• Potential mechanisms include 5alpha-reductase inhibition and alpha-adrenergic antagonism.
• Some phytotherapeutic agents demonstrate significant efficacy with mild side effects, while others require more clinical evidence.

Conclusions:

• Phytotherapy, including specific herbal agents, can be beneficial for managing benign prostatic hyperplasia (BPH) symptoms.
• Healthcare providers should consider the risk/benefit profile of medicinal plants in BPH treatment.
• Continued research and clinical trials are essential to further establish the role of phytotherapy in BPH care.